{"database": "lobbying", "table": "lobbying_activities", "rows": [[1183856, "20b8f89e-c61f-4d40-b6a1-3913a00655d6", "Q4", "BUCHANAN INGERSOLL & ROONEY PC", 55291, "SHIRE PHARMACEUTICALS INC", 2011, "fourth_quarter", "PHA", "Life Sciences Investment Act; ESRD orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues; PDUFA; exclusivity periods", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2012-01-11T17:17:20-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1183856"], "units": {}, "query_ms": 16.370879020541906, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}